| Cell line name |
H3477 |
|---|
| Synonyms |
HBT 3477; HBT-3477; HBT3477 |
|---|
| Accession |
CVCL_D350 |
|---|
| Secondary accession |
CVCL_JY55 |
|---|
| Resource Identification Initiative |
To cite this cell line use: H3477 (RRID:CVCL_D350) |
|---|
| Comments |
From: Bristol-Myers Squibb Pharmaceutical Research Institute; Seattle; USA. |
|---|
| Disease |
Breast carcinoma (NCIt: C4872) |
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Sex of cell |
Female |
|---|
| Age at sampling |
Age unspecified |
|---|
| Category |
Cancer cell line |
|---|
| Publications | PubMed=9108094; DOI=10.1073/pnas.94.8.4000; PMCID=PMC20557
Sally Jacobson DeNardo, David L. Kukis, Linda A. Kroger, Robert T. O'Donnell, Kathleen Rundle Lamborn, Laird A. Miers, David G. DeNardo, Claude F. Meares, Gerald L. DeNardo;
Synergy of taxol and radioimmunotherapy with yttrium-90-labeled chimeric L6 antibody: efficacy and toxicity in breast cancer xenografts.
Proc. Natl. Acad. Sci. U.S.A. 94:4000-4004(1997) PubMed=9186000
Jing-Wen Liu, Michael J. Spence, Philip M. Wallace, Kristin Forcier, Ingegerd Hellstrom, Robert E. Vestal;
Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene.
Cell Growth Differ. 8:667-676(1997) PubMed=11839257; DOI=10.1089/15368590152740798
James David Pancook, Gregory Beuerlein, Gerlinde Pecht, Ying Tang, Ying Nie, Herren Wu, William D. Huse, Jeffry D. Watkins;
In vitro affinity maturation of human IgM antibodies reactive with tumor-associated antigens.
Hybrid. Hybridomics 20:383-396(2001) |
|---|
| Cross-references |
|---|
| Encyclopedic resources |
Wikidata; Q54872073
|
|---|
| Entry history |
|---|
| Entry creation | 22-Oct-2012 |
|---|
| Last entry update | 21-Mar-2023 |
|---|
| Version number | 8 |
|---|
